C-terminal fragment of tetanus toxin: Its use in neuronal network analysis and its potential as non-viral vector;Utilisation du fragment C-terminal de la neurotoxine tétanique pour visualiser et analyser des connexions neuronales et pour le transfert d'une activité biologique associée

Journal de la Societe Biologie

Volumn 199, Issue 1, 2005, Pages 35-44

  Roux, Sylvie ^a,b   Saint Cloment, Cécile ^b   Curie, Thomas ^b   Girard, Emmanuelle ^a   Brûlet, Philippe ^b   Molgó, Jordi ^a  

^a LABORATOIRE DE NEUROBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE;

EID: 23444450253     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2005005     Document Type: Conference Paper

References (73)

1. Anderson R. G. W., The caveolae membrane system. Annu. Rev. Biochem., 1998, 67, 199-225.
2. Ariansen S., Afanasiev B. N., Moskaug J. O., Stenmark H., Madshus I. H. & Olsnes S., Membrane translocation of diphteria toxin A-fragment: role of carboxy-terminal region. Biochemistry, 1993, 32, 83-90.
3. Barati S., Chegini F., Hurtado P. & Rush R. A., Hybrid tetanus toxin C fragment-diphteria toxin translocation domain allows specific gene transfer into PC12 cells. Exp. Neurol., 2002, 177, 75-87.
4. Beaude P., Delacour A., Bizzini B., Domuado D. & Remy M.-H., Retrograde axonal transport of an exogenous enzyme covalently linked to B-IIb fragment of tetanus toxin. Biochem. J., 1990, 271, 87-91.
5. Bizzini B., Grob P., Glicksman M. A. & Akert K., Use of the B-IIb tetanus toxin derived fragment as a specific neuropharmacological transport agent. Brain Res., 1980, 193, 221-227.
6. Bordet T., Castelnau-Ptakhine L., Fauchereau F., Friocourt G., Kahn A. & Haase G., Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment. Mol. Cell. Neurosci., 2001a, 17, 842-854.
7. Bordet T., Lesbordes J. C., Rouhani S., Castelnau-Ptakhine L., Schmalbruch H., Haase G. & Kahn A., Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum. Mol. Genet., 2001b, 10, 1925-1933.
8. Bordet T., Schmalbruch H., Pettman B., Hagege A., Castelnau-Ptakhine L., Kahn A. & Haase G., Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy. J. Clin. Invest., 1999, 104, 1077-1085.
9. Brown A., Axonal transport of membranous and nonmembranous cargoes: a unified perspective. J. Cell Biol., 2003, 160, 817-821.
10. Coco S., Raposo G., Martinez S., Fontaine J.-J., Takamori S., Zahraoui A., Jahn R., Matteoli M., Louvard D. & Galli T., Subcellular localization of tetanus neurotoxin-insensitive vesicle-associated membrane protein (VAMP)/VAMP7 in neuronal cells: evidence for a novel membrane compartment. J. Neurosci., 1999, 19, 9803-9812.
11. Coen L., Kissa K., Le Mevel S., Brûlet P. & Demeneix B. A., A somatic gene transfer approach using recombinant fusion proteins to map muscle-motoneuron projections in Xenopus spinal cord. Int. J. Dev. Biol., 1999, 43, 823-830.
12. Coen L., Osta R., Maury M. & Brûlet P., Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system. Proc. Natl. Acad. Sci. USA, 1997, 94, 9400-9405.
13. DeFalco J., Tomishima M., Liu H., Zhao C., Cai X., Marth J. D., Enquist L. & Friedman J. M., Virus-assisted mapping of neuronal inputs to a feeding center in the hypothalamus. Science, 2001, 291, 2608-2613.
14. Dobrenis K., Joseph A. & Rattazzi M. C., Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin. Proc. Natl. Acad. Sci. USA, 1992, 89, 2297-2301.
15. Figueiredo D. M., Hallewell R. A., Chen L. L., Fairweather N. F., Dougan G., Savitt J. M., Parks D. A. & Fishman P. S., Delivery of recombinant tetanus-superoxide dismutase to central nervous system neurons by retrograde axonal transport. Exp. Neurol., 1997, 145, 546-554.
16. Figueiredo D. M., Matthews C. C., Parks D. A., Fairweather N. F., Dougon G., Wilt S. G. & Fishman P. S., Interaction of tetanus toxin derived hybrid proteins with neuronal cells. J. Nat. Toxins, 2000, 9, 363-379.
17. Fishman P. S. & Savitt J. M., Transsynaptic transfer of retrogradely transported tetanus protein-peroxidase conjugates. Exp. Neurol., 1989, 106, 197-203.
18. Francis J. W., Bastia E., Matthews C. C., Parks D. A., Schwarzschild M. A., Brown Jr R. H. & Fishman P. H., Tetanus toxin fragment C as a vector to enhance delivery of proteins to the CNS. Brain Res., 2004a, 1011, 7-13.
19. Francis J. W., Brown R. H., Figueiredo D., Remington M. P., Castillo O., Schwarzschild M. A., Fishman P. S., Murphy J. R. & van der Spek J. C., Enhancement of Diphteria toxin potency by replacement of receptor binding domain with tetanus toxin C-fragment: a potential vector for delivering heterologous proteins to neurons. J. Neurochem., 2000, 74, 2528-2536.
20. Francis J. W., Figueiredo D., vanderSpek J. C., Ayala L. M., Kim Y. S., Remington M. P., Young P. J., Lorson C. L., Ikebe S., Fishman P. S. & Brown Jr R. H., A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neuron. Brain Res., 2004b, 995, 84-96.
21. Francis J. W., Hosler B. A., Brown R. H. & Fishman P. S., CuZn superoxide dismutase (SOD-1): tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells. J. Biol. Chem., 1995, 270, 15434-15442.
22. Francis J. W., Ren J. M., Warren L., Brown Jr R. H. & Finklestein S. P., Postischemic infusion of Cu/Zn superoxide dismutase or SOD:Tet451 reduces cerebral infarction following focal ischemia/reperfusion in rats. Exp. Neurol., 1997, 146, 435-433.
23. Gil C., Chaib I., Blasi J. & Aguilera J., Hc fragment of tetanus toxin activates proteinkinase C isoforms and phosphoproteins involved in signal transduction. Biochem. J., 2001, 356, 97-103.
24. Gil C., Chaib I., Pellicioni P. & Aguilera J., Activation of signal transduction pathways involving TrkA, PLCg, PKC isoforms and ERK-1/2 by tetanus toxin. FEBS, 2000, 481, 177-182.
25. Gil C., Chaib-Oukadour I. & Aguilera J., C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signaling pathways in a Trk receptor-dependent manner in cultured cortical neurons. Biochem. J., 2003, 373, 613-620.
26. Goldstein L. S. B. & Yang Z., Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu. Rev. Neurosci., 2000, 23, 39-71.
27. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A. S., Hummerich H., Nicholson S., Morgan P. J., Oozageer R., Priestley J. V., Averill S., King V. R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D. T., Russ A. P., Stumm G., Martin J. E. & Fisher E. M. C., Mutations in dynein link motor neuron degeneration to defects in retro-grade transport. Science, 2003, 300, 808-812.
28. Halpern J. L. & Neale E. A., Neurospecific binding, internalization, and retrograde axonal transport. Curr. Top. Microbiol. Immunol., 1995, 195, 221-241.
29. Harder T., Scheiffele P., Verkade P. & Simons K., Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol., 1998, 141, 929-942.
30. Herreros J., Lalli G., Montecucco C. & Schiavo G., Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons. J. Neurochem., 2000a, 74, 1941-1950.
31. Herreros J., Lalli G. & Schiavo G., C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. Biochem. J., 2000b, 347, 199-204.
32. Herreros J., Ng T. & Schiavo G., Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol. Biol. Cell, 2001, 12, 2947-2960.
33. Herreros J. & Schiavo G., Lipid microdomains are involved in neurospecific binding and internalisation of clostridial neurotoxins. Int. J. Med. Microbiol., 2002, 291, 447-453.
34. Kissa K., Mordelet E., Soudais C., Kremer E., Demeneix B. A., Brûlet P. & Coen L., In vivo neuronal tracing with GFPTTC gene delivery. Mol. Cell. Neurosci., 2002, 20, 627-637.
35. Klingenberg O. & Olsnes S., Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphteria toxin. Biochem. J., 1996, 313, 647-653.
36. Knight A., Carvajal J., Schneider H., Coutelle C., Chamberlain S. & Fairweather N., Non-viral neuronal gene delivery mediated by the Hc fragment of tetanus toxin. Eur. J. Biochem., 1999, 259, 762-769.
37. Kremer E., Boutin S., Chillon M. & Danos O., Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfert. J. Virol., 2000, 74, 505-512.
38. Kuypers H. G. J. M. & Ugolini G., Viruses as transneuronal tracers. Trends Neurosci., 1990, 13, 71-75.
39. Lacy D. B., Tepp W., Cohen A. C., DasGupta B. R. & Stevens R. C., Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol., 1998, 5, 898-902.
40. Lalli G., Gschmeissner S. & Schiavo G., Myosin Va and microtubule-based motors are required for fast axonal retrograde transport of tetanus toxin in motor neurons. J. Cell Science, 2003, 116, 4639-4650.
41. NTR. J. Cell Biol., 2002, 156, 233-239.
42. LaMonte B. H., Wallace K. E., Holloway B. A., Shelly S. S., Ascano J., Tokito M., Van Winkle T., Rowland D. S. & Holzbaur E. L. F., Disruption of Dynein/Dynactin inhibits axonal transport in motor neurones causing late-onset progressive degeneration. Neuron, 2002, 34, 715-727.
43. Lefevre S., Burlet Q., Liu S., Bertrandy O., Clermont A., Munnich G., Dreyfuss G. & Melki J., Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet., 1997, 16, 265-269.
44. Lesbordes J. C., Cifuentes-Diaz C., Miroglio A., Joshi V., Bordet T., Kahn A. & Melki J., Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. Hum. Mol. Genet., 2003, 12, 1233-1239.
45. London E., Diphteria toxin: membrane interaction and membrane translocation. Biochem. Biophys. Acta, 1992, 1113, 25-51.
46. Madshus I. H., Olsnes S. & Stenmark H., Membrane translocation of diphteria toxin carrying passenger protein domains. Infect. Immun., 1992, 60, 3296-3302.
47. Manning K. A., Erichsen J. T. & Evinger C., Retrograde transneuronal transport properties of fragment C of tetanus toxin. Neuroscience, 1990, 34, 251-263.
48. Maskos U., Kissa K., Saint Cloment C. & Brûlet P., Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice. Proc. Natl. Acad. Sci. USA, 2002, 99, 10120-10125.
49. Matteoli M., Verderio C., Rossetto O., Iezzi N., Coco S., Schiavo G. & Montecucco C., Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc. Natl. Acad. Sci. USA, 1996, 93, 13310-13315.
50. Miana-Mena F. J., Muñoz M. J., Ciriza J., Soria J., Brûlet P., Zaragoza P. & Osta R., Fragment C tetanus toxin: a putative activity-dependent neuroanatomical tracer. Acta Neurobiol. Exp., 2003, 63, 211-218.
51. Miana-Mena F. J., Muñoz M. J., Roux S., Ciriza J., Zaragoza P., Brûlet P. & Osta R., A non-viral vector for targeting gene therapy to motoneurons in the CNS. Neurodegenerative Dis., 2004, 1, sous presse.
52. Miana-Mena F. J., Roux S., Bénichou J.-C., Osta R. & Brûlet P., Neuronal activity-dependent membrane traffic at the neuromuscular junction. Proc. Natl. Acad. Sci. USA, 2002, 99, 3234-3239.
53. Monani U., Sendtner M., Coovert D. D., Parsons D. W., Andreassi C., Le T. T., Jablonka S., Schrank B., Rossol W., Prior T. W., Morris G. E. & Burghes A. H. M., The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet., 2000, 9, 333-339.
54. Montecucco C., How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem. Sci., 1986, 11, 314-317.
55. Murakami T., Nagano I., Hayashi T., Manabe Y., Shoji M., Setoguchi Y. & Abe K., Impaired retrograde axonal transport of adenovirus-mediated E. Coli LacZ gene in mice carrying mutant SOD1 gene. Neurosci. Lett., 2001, 308, 149-152.
56. Orrell R. W., Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD-1) gene mutations. Neuromusc. Disord., 2000, 10, 63-68.
57. Pelkmans L., Kartenbeck J. & Helenius A., Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol., 2001, 3, 473-483.
58. Prochiantz A., Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol., 2000, 12, 400-406.
59. Sapir T., Geiman E. J., Wang Z., Velasquez T., Mitsui S., Yoshihara Y., Frank E., Alvarez F. J. & Goulding M., Pax6 and Engrailed1 regulate two distinct aspects of Renshaw cell development. J. Neurosci., 2004, 24, 1255-1264.
60. Schiavo G., Matteoli M. & Montecucco C., Neurotoxins affecting neuroexocytosis. Physiol. Rev., 2000, 80, 717-766.
61. Schneider H., Groves M., Mühle C., Reynolds P. N., Knight A., Themis M., Carvajal J., Scaravilli F., Curiel D. T., Fairweather N. F. & Coutelle C., Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin. Gene Ther., 2000, 7, 1584-1592.
62. Schneider S. P. & Fyffe R. E. W., Involvement of GABA and glycine in recurrent inhibition of spinal motor neurons. J. Neurophysiol., 1992, 68, 397-406.
63. Shin J. S. & Abraham S. N., Co-option of endocytic functions of cellular caveolae by pathogens. Immunology, 2001, 102, 2-7.
64. Siegel G. J. & Chauhan N. B., Neurotrophic factor in Alzheimer's and Parkinson's disease brain. Brain Res. Rev., 2000, 33, 199-227.
65. Simons K. & Toomre D., Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol., 2000, 1, 31-40.
66. Stenmark H., Moskaug J. O., Madshus I. H., Sandvig K. & Olsnes S., Peptides fused to the amino-terminal end of diphteria toxin are translocated to the cytosol. J. Cell Biol., 1991, 113, 1025-1032.
67. Swaminathan S. & Eswaramoorthy S., Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol., 2000, 7, 693-699.
68. Ugolini G., Transneuronal tracing with α-herpesviruses: a review of the methodology. In viral vectors. Gene therapy and Neuroscience Applications. Academic Press, 1995, 293-317.
69. Umland T. C., Wingert L. M., Swaminathan S., Furey W. F., Schmidt J. J. & Sax M., Structure of the receptor binding fragment HC of tetanus neurotoxin. Nat. Struct. Biol., 1997, 4, 788-792.
70. 389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. J. Biol. Chem., 1993, 268, 12077-12082.
71. 389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-receptor interactions. J. Biol. Chem., 1996, 271, 12145-12149.
72. Vyas K. A., Patel H. V., Vyas A. A. & Schnaar R. L., Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol. Chem., 2001, 382, 241-250.
73. Williamson T. L. & Cleveland D. W., Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci., 1999, 2, 50-56.